Brief: Dyadic Announces Development Of Covid-19 Vaccine In India
May 26 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC ANNOUNCES DEVELOPMENT OF COVID-19 VACCINE IN INDIA
* DYADIC INTERNATIONAL INC - WILL WORK WITH SYNGENE TO
DEVELOP A
VACCINE CANDIDATE TO IMMUNIZE PEOPLE AGAINST CURRENT AND FUTURE
VARIANTS OF COVID-19 VIRUS
* DYADIC INTERNATIONAL - ENTERED INTO COLLABORATION WITH
SYNGENE
INTERNATIONAL TO DEVELOP COVID-19 VACCINE CANDIDATE THAT CAN
PROTECT AGAINST EMERGING VARIANTS
Source text for Eikon: ID:nGNX3gkNJC
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development